Literature DB >> 6176945

Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

R Devos, H Cheroutre, Y Taya, W Degrave, H Van Heuverswyn, W Fiers.   

Abstract

Starting with mRNA derived from Staphylococcal enterotoxin A induced human splenocytes, dsDNA was synthesized and inserted into unique BamHI site of the eukaryotic expression vector pSV529 (1). A recombinant plasmid containing human immune interferon (IFN-gamma) cDNA was identified by hybridization of plasmid inserted DNA bound onto nitrocellulose filters with mRNA derived from SEA-induced splenocytes, translation of the eluted RNA in Xenopus laevis oocytes and assaying for IFN activity. Plasmids containing the entire human IFN-gamma cDNA sequence were identified by colony hybridization and were sequenced. A unique coding region was identified which predicted a protein of 166 amino acids, the 20 N-terminal amino acids of which presumably represent a signal peptide. After transfection of monkey cells with plasmid DNA isolated from one of the recombinant clones (pHIIF-SV-gamma 1), IFN was excreted into the culture medium. This IFN was not distinguishable from human IFN-gamma by serological criteria or by cell target species specificity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176945      PMCID: PMC320629          DOI: 10.1093/nar/10.8.2487

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  Interferon-gamma: success, structure and speculation.

Authors:  L B Epstein
Journal:  Nature       Date:  1982-02-11       Impact factor: 49.962

2.  Molecular weight of human gamma interferon is similar to that of other human interferons.

Authors:  Y K Yip; B S Barrowclough; C Urban; J Vilcek
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

3.  Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.

Authors:  J E Blalock; J A Georgiades; M P Langford; H M Johnson
Journal:  Cell Immunol       Date:  1980-02       Impact factor: 4.868

4.  Evaluation of T lymphocyte effector function in immunodeficiency diseases: abnormality in mitogen-stimulated interferon in patients with selective IgA deficiency.

Authors:  L B Epstein; A J Ammann
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  The mechanism of protein secretion across membranes.

Authors:  B D Davis; P C Tai
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

6.  gamma-Interferon induced by S. aureus protein A augments natural killing and ADCC.

Authors:  W J Catalona; T L Ratliff; R E McCool
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

7.  Partial purification and characterization of human gamma (immune) interferon.

Authors:  Y K Yip; R H Pang; C Urban; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells.

Authors:  H Ankel; C Krishnamurti; F Besançon; S Stefanos; E Falcoff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

9.  Interferon production by human and murine lymphocytes in response to alloantigens.

Authors:  B Perussia; L Mangoni; H D Engers; G Trinchieri
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

10.  Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin.

Authors:  E F Wheelock
Journal:  Science       Date:  1965-07-16       Impact factor: 47.728

View more
  37 in total

1.  IL-9 promotes anti-Mycobacterium leprae cytotoxicity: involvement of IFNgamma.

Authors:  M R Finiasz; M C Franco; S de la Barrera; L Rutitzky; G Pizzariello; M del Carmen Sasiain; J-C Renauld; J Van Snick; S Fink
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Inherited human IFN-γ deficiency underlies mycobacterial disease.

Authors:  Gaspard Kerner; Jérémie Rosain; Antoine Guérin; Ahmad Al-Khabaz; Carmen Oleaga-Quintas; Franck Rapaport; Michel J Massaad; Jing-Ya Ding; Taushif Khan; Fatima Al Ali; Mahbuba Rahman; Caroline Deswarte; Rubén Martinez-Barricarte; Raif S Geha; Valentine Jeanne-Julien; Diane Garcia; Chih-Yu Chi; Rui Yang; Manon Roynard; Bernhard Fleckenstein; Flore Rozenberg; Stéphanie Boisson-Dupuis; Cheng-Lung Ku; Yoann Seeleuthner; Vivien Béziat; Nico Marr; Laurent Abel; Waleed Al-Herz; Jean-Laurent Casanova; Jacinta Bustamante
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma.

Authors:  E M Lemmel; M Franke; W Gaus; P W Hartl; P H Hofschneider; K Miehlke; K Machalke; H J Obert
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

4.  Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.

Authors:  A Takeda; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Interleukin 2-activated killer cells: generation in collaboration with interferon gamma and its suppression in cancer patients.

Authors:  K Shiiba; R Suzuki; K Kawakami; A Ohuchi; K Kumagai
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Undermethylation of interferon-gamma gene in human T cell lines and normal T lymphocytes.

Authors:  R Fukunaga; M Matsuyama; H Okamura; K Nagata; S Nagata; Y Sokawa
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

7.  Source of heterogeneity in secreted interferon-gamma. A study on products of translation in vitro.

Authors:  N J Bulleid; E Curling; R B Freedman; N Jenkins
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

8.  Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.

Authors:  A Y Kwok; X Zu; C Yang; M J Alfa; F T Jay
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

9.  Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma.

Authors:  W Heagy; V E Kelley; T B Strom; K Mayer; H M Shapiro; R Mandel; R Finberg
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Lymphokine production by human melanoma tumor-infiltrating lymphocytes.

Authors:  M A Salmeron; T Morita; H Seki; C D Platsoucas; K Itoh
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.